EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of m6A reader IGF2BPs in tumor metabolic reprogramming

Xin Zhou, Guohua Li, Xiaoling Su, Yanpeng Wang, Li Liu, Chaoying Yang, Yao Xu, Jun He, Ji Zhang

Biochemical Pharmacology · 2026-01 · 243 · 117452

DOI: 10.1016/j.bcp.2025.117452 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2026-01. Verfasst von Xin Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Nanhua Hospital, Department of Clinical Laboratory, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China. Hauptthemen laut MEDLINE: Neoplasms, RNA-Binding Proteins, Adenosine, Cellular Reprogramming. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 196 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin-like growth factor II mRNA-binding proteins (IGF2BPs) regulate the metabolic reprogramming of tumor cells via N6-methyladenosine (m6A) modification, promoting rapid proliferation and malignant progression. The RNAs of key metabolic enzymes are regulated by IGF2BPs through diverse mechanisms in critical pathways, including aerobic glycolysis, lipid metabolism, and amino acid metabolism. However, the specific molecular mechanisms involved in cancer metabolism have not been fully elucidated. This review systematically summarizes the pivotal regulator of IGF2BPs in tumor metabolism, including aerobic glycolysis, lipid metabolism and amino acid metabolism, which explores the biological functions and potential therapeutic targets of IGF2BPs in various tumors. Herein, targeting the regulation of IGF2BPs activity in the regulation of cell metabolism is highly beneficial in the diagnosis and treatment of various tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRNA-Binding ProteinsAdenosineCellular ReprogrammingHumansAnimalsLipid MetabolismGlycolysisInsulin-Like Growth Factor IIMetabolic Reprogramming

Stichwörter der Autor:innen

Aerobic glycolysisAmino acid metabolismIGF2BPsLipid metabolismMetabolic reprogrammingm6A modification

Substanzen

RNA-Binding ProteinsAdenosineN-methyladenosineInsulin-Like Growth Factor II

Autor:innen und Institutionen

  • The Affiliated Nanhua Hospital, Department of Clinical Laboratory, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China.
  • Institute of Cardiovascular Disease, Key Laboratory for Arteriosclerology of Hunan Province, Hunan International Scientific and Technological Cooperation Base of Arteriosclerotic Disease, Department of Pathophysiology,…
  • Hunan Province Key Laboratory of Basic and Applied Hematology, Molecular Biology Research Center & Center for Medical Genetics, School of Life Sciences, Central South University, Changsha 410078 Hunan, China.
  • The Affiliated Nanhua Hospital, Department of Hepatobiliary Surgery, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China. Electronic address: 1684131533@qq.com.
  • The Affiliated Nanhua Hospital, Department of Clinical Laboratory, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, China. Electronic address: zhang_ji001@hotmail.com.

Förderung

  • Hunan Provincial Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, X., Li, G., Su, X., Wang, Y., Liu, L., Yang, C., Xu, Y., He, J., & Zhang, J. (2026). The role of m6A reader IGF2BPs in tumor metabolic reprogramming. Biochemical Pharmacology, 243, 117452. https://doi.org/10.1016/j.bcp.2025.117452

Vancouver

Zhou X, Li G, Su X, Wang Y, Liu L, Yang C, et al. The role of m6A reader IGF2BPs in tumor metabolic reprogramming. Biochemical Pharmacology. 2026;243:117452. doi:10.1016/j.bcp.2025.117452

BibTeX
@article{Zhou2026,
  author = {Zhou, Xin and Li, Guohua and Su, Xiaoling and Wang, Yanpeng and Liu, Li and Yang, Chaoying and Xu, Yao and He, Jun and Zhang, Ji},
  title = {The role of m6A reader IGF2BPs in tumor metabolic reprogramming},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {243},
  pages = {117452},
  doi = {10.1016/j.bcp.2025.117452}
}
Kostenlos starten →